bioMérieux

bioMérieux is a global leader in the field of in vitro diagnostics, dedicated to improving public health by providing innovative solutions for disease diagnosis and monitoring. Established in 1963, the company has consistently focused on developing cutting-edge technologies that enhance laboratory efficiency and accuracy.

With a presence in over 150 countries, bioMérieux offers a wide range of products and services that cater to various sectors, including clinical diagnostics, industrial microbiology, and food safety. The company’s commitment to research and development has led to numerous breakthroughs in diagnostic testing, enabling healthcare professionals to make informed decisions quickly.

bioMérieux’s core activities include:

• Development of diagnostic tests for infectious diseases.
• Providing solutions for antimicrobial susceptibility testing.
• Offering systems for blood culture and identification.
• Delivering innovative tools for molecular biology and microbiology.

The company’s vision is to be at the forefront of innovation in diagnostics, ensuring that healthcare providers have access to the most reliable and efficient tools available. bioMérieux is also committed to sustainability and corporate social responsibility, actively working to reduce its environmental impact and improve access to healthcare worldwide.

Through strategic partnerships and collaborations, bioMérieux continues to expand its portfolio and enhance its capabilities, striving to meet the evolving needs of the healthcare industry. The company’s dedication to quality and excellence has earned it a reputation as a trusted partner in the fight against infectious diseases.